跳至主要内容
临床试验/CTRI/2024/04/065861
CTRI/2024/04/065861尚未招募不适用

Study of efficacy of tranexamic acid in reducing blood loss and postoperative complications in breast surgery

Dr Hariharan R1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. Effect of tranexamic acid in reducing postoperative bleeding

研究概览

简要总结

Aim to study the effect of tranexamic acid in reducing blood loss and postoperative complications in patients undergoing breast surgery

1g tranexamic acid will be given to the study group 1 dose preoperative and 3 doses in the 1st 24 hrs postoperative period and the postoperative pain and blood loss will be compared to the control group

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
Female

入选标准

  • All females above 18 yrs of age undergoing breast surgery who consent to the study.

排除标准

  • Patients not giving consent Patients with uncontrolled comorbidities History of prior thromboembolic events Patients with severe renal impairment Patients with seizure disorder Patients with retinal vein occlusion.

结局指标

主要结局

1. Effect of tranexamic acid in reducing postoperative bleeding

时间窗: 4 weeks

2 effect of tranexamic acid in reducing postoperative pain

时间窗: 4 weeks

3 effect of tranexamic acid in reducing other postoperative complications

时间窗: 4 weeks

次要结局

  • 1 Effect of tranexamic acid in reducing other postoperative complications(4 weeks)

研究者

发起方
Dr Hariharan R
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Hariharan R

Govt Stanley medical college

研究点 (1)

Loading locations...

相似试验